Table 6.

Mortality rate ratios (MRR) for trial participants above 6 months of age after the H1N1 campaign compared with before the H1N1 campaign in 2010.

Trial Intervention	Recruitment period	Age group	MRR (H1N1/noH1N1)	Males	Females
V. BCG-at-birth vs delayed BCG to LBW children	2008–2013	0–11 months	2.16 (0.94–4.99)	#	2.28 (0.98–5.27)
VI. OPV + BCG vs BCG-only	2008–2011	0–11 months	1.44 (0.52–3.96)	0.71 (0.10–5.13)	2.19 (0.68–7.08)
VII. VAS vs placebo with vaccines; 12 months follow-up	2007–2010	6–17 months	6.48 (1.42–29.6)	4.63 (0.58–36.9)	9.84 (1.20–81.0)
Combined result			1.86 (1.02–3.42)	0.95 (0.23–3.92)	2.32 (1.19–4.52)

^#Prior to the campaign, only females were included in the randomized controlled trial and an estimate could, therefore, not be made for males.